StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

Bullboard Posts

Comment by MAJ427on Sep 23, 2020 1:35pm

150 Views

Post# 31605002

RE:RE:What a piss off

While it's extremely frustrating, let's not forget that last week at this time we were sitting at $0.06 ($0.48 post split) and we opened at $0.72 once the RS was completed. A little pull back was expected after the run we've been on this week. Let's just hope it's some healthy consolidation and we can bounce back tomorrow.

For your sake I hope you're able to get back in, I'd hate to see anyone miss out when this launches. Life changing money to be had for the patient

Bullboard Posts

Advancing flagship Ishkõday Gold Project in Ontario